Jul 21-27 (Week 30) & Jul 28-Aug 3, 2025 (Week 31)

🔹 Jul 21-27, 2025 -- Highlights

• 3 cost-conscious fertility startups that are making egg-freezing more accessible
• Permira, Nordic in Takeover Talks for Vaccine Maker Bavarian
• Gate Bioscience Enters into a Collaboration and License Agreement with Lilly
• Provectus Algae Raises $12.6M in Series A Led by At One Ventures and Grant Funding
• Real Chemistry Deepens Media and Technology Edge With Acquisition of Greater Than One
• PharmAla Issues Q3 Financial Statements

🔹 Jul 28-Aug 3, 2025 -- Highlights

• Aptose Selects Ernst & Young Global Limited as its New Independent Auditor and Calls Reconvened Meeting of its Shareholders
• Genvira and Labskin Receive £1.2 Million ($2.0 Million) UK–Canada Collaboration Award to Advance Immunotherapies for Malignant Melanoma
• Altasciences and VoxCell BioInnovation Announce Strategic Collaboration to Advance Preclinical Drug Development
• Dr. Falk Pharma and Allianthera Forge Strategic Partnership for Novel AhR Agonist Development
• ProMIS Neurosciences to Showcase Protein-Misfolding Drug Discovery Platform & PRECISE-AD Trial Design at the 2025 Alzheimer’s Association International Conference
• AltPep Corporation Presents New Preclinical Data at AAIC 2025 Demonstrating SOBIN-AD
• Quantum BioPharma Licensee Unbuzzd Wellness Inc. Commences Reg D Capital Raise Campaign
• K